Staurosporine modulates radiosensitivity and radiation-induced apoptosis in U937 cells

International Journal of Radiation Biology

Volumn 82, Issue 2, 2006, Pages 97-109

  Guo, How Ran ^a   Chen, Chia Hsin ^a   Ho, Sheng Yow ^a,b   Ho, Yuan Soon ^c   Chen, Rong Jane ^a   Wang, Ying Jan ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN SIN LAU HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cell cycle checkpoints; Chemical modifiers; Leukaemias; Radiotherapy

Indexed keywords

CASPASE; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL STRAIN U937; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRRADIATION; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RADIOSENSITIVITY; SARCOMA VIRUS; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; HUMANS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; STAUROSPORINE; U937 CELLS;

EID: 33645166806     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000600589149     Document Type: Article

References (71)

1. Abu-Qare AW, Abou-Donia MB. 2001. Biomarkers of apoptosis: Release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′- deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. Journal of Toxicology and Environmental Health B Critical Reviews 4:313-332.
2. Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M, Okamoto T. 2001. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. Journal of Biological Chemistry 276:42971-42977.
3. Bossy-Werzel E, Newmeyer DD, Green DR. 1998. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO Journal 17:37-49.
4. Bracey TS, Williams AC, Paraskeva C. 1997. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clinical Cancer Research 3:1371-1381.
5. Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN. 2000. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChkl. Cancer Research 60:2108-2112.
6. Cano E, Mahadevan LC. 1995. Parallel signal processing among mammalian MAPKs. Trends in Biochemical Sciences 20:117-122.
7. Cartee L, Sankala H, Davis C, Smith R, Maggio S, Lin PS, Dent P, Grant S. 2002. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism. International Journal of Oncology 21:351-359.
8. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P. 1998. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 16:2787-2796.
9. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM. 1997. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nature Medicine 3:227-230.
10. Cory S, Adams JM. 2002. The Bcl2 family: Regulators of the cellular life-or-death switch. National Review of Cancer 2:647-656.
11. Davis RJ. 1994. MAPKs: New JNK expands the group. Trends in Biochemical Sciences 19:470-473.
12. Ding Z, Parchment RE, LoRusso PM, Zhou JY, Li J, Lawrence TS, Sun Y, Wu GS. 2001. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways. Clinical Cancer Research 7:3336-3342.
13. Du L, Lyle CS, Obey TB, Gaarde WA, Muir JA, Bennett BL, Chambers TC. 2004. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: Evidence that mitotic Bcl-2 phosphorylation is JNK-independent. Journal of Biological Chemistry 279:11957-11966.
14. Enomoto A, Suzuki N, Hirano K, Matsumoto Y, Morita A, Sakai K, Koyama H. 2000. Involvement of SAPK/JNK pathway in X-ray-induced rapid cell death of human T-cell leukemia cell line MOLT-4. Cancer Letters 155:137-144.
15. Enomoto A, Suzuki N, Liu C, Kang Y, Zhu J, Serizawa S, Matsumoto Y, Morita A, Ito M, Hosoi Y. 2001. Involvement of c-Jun NH2-terminal kinase-1 in heat-induced apoptotic cell death of human monoblastic leukaemia U937 cells. International Journal of Radiation Biology 77:867-874.
16. Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, Rosen EM. 1998. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. International Journal of Cancer 77:600-609.
17. Giaccia AJ, Kastan MB. 1998. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes & Development 12:2973-2983.
18. Gil J, Almeida S, Oliveira CR, Rego AC. 2003. Cytosolic and mitochondrial ROS in staurosporine-induced retinal cell apoptosis. Free Radicals Biology and Medicine 35:1500-1514.
19. Gross A, McDonnell JM, Korsmeyer SJ. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes & Development 13:1899-1911.
20. Harada K, Ogden GR. 2000. An overview of the cell cycle arrest protein, p21 (WAF1). Oral Oncology 36:3-7.
21. Heerdt BG, Houston MA, Mariadason JM, Augenlicht LH. 2000. Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonie carcinoma cells: Initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). Cancer Research 60:6704-6713.
22. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
23. Herskowitz I. 1995. MAP kinase pathways in yeast: For mating and more. Cell 80:187-197.
24. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
25. Huang DC, Strasser A. 2000. BH3-Only proteins-essential initiators of apoptotic cell death. Cell 103:839-842.
26. Ip YT, Davis RJ. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Current Opinion Cell Biology 10:205-219.
27. Johnson NL, Gardner AM, Diener KM, Lange-Carter CA, Gleavy J, Jarpe MB, Minden A, Karin M, Zon LI, Johnson GL. 1996. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. Journal of Biological Chemistry 271:3229-3237.
28. Kihara C, Seki T, Furukawa Y, Yamana H, Kimura Y, van Schaardenburgh P, Hirata K, Nakamura Y. 2000. Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients. Japanese Journal of Cancer Research 91:190-198.
29. Kinzler KW, Vogelstein B. 1996. Life (and death) in a malignant tumour. Nature 379:19-20.
30. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. 1997. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
31. Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O'Connell MJ. 2001. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 20:7453-7463.
32. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
33. Lin YP, Zhu BZ, Yang MC, Frei B, Pan MH, Lin JK, Wang YJ. 2004. Bcl-2 overexpression inhibits tetrachlorohydroquinone-induced apoptosis in NIH3T3 cells: A possible mechanism for tumor promotion. Molecular Carcinogenesis 40:24-33.
34. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-157.
35. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810.
36. Lowe SW, Ruley HE, Jacks T, Housman DE. 1993a. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
37. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
38. Maggiorella L, Deutsch E, Frascogna V, Chavaudra N, Jeanson L, Milliat F, Eschwege F, Bourhis J. 2003. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo. Cancer Research 63:2513-2517.
39. Maity A, McKenna WG, Muschel RJ. 1994. The molecular basis for cell cycle delays following ionizing radiation: A review. Radiotherapy and Oncology 31:1-13.
40. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. 1997. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. Journal of Experimental Medicine 186:785-793.
41. Martelli AM, Cappellini A, Tazzari PL, Billi AM, Tassi C, Ricci F, Fala F, Conte R. 2004. Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes. Haematologica 89:471-479.
42. Matsui Y, Tsuchida Y, Keng PC. 2001. Effects of p53 mutations on cellular sensitivity to ionizing radiation. American Journal of Clinical Oncology 24:486-490.
43. Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL. 2004. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 23:596-604.
44. Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y, Yasuda T, Yano M, Inoue M, Shiozaki H, Weinstein IB, Monden M. 2001a. Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Research 61:3188-3193.
45. Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y, Yasuda T, Yano M, Inoue M, Shiozaki H, Weinstein IB, Monden M. 2001b. Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Research 61:3188-3193.
46. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T. 1997. p27 expression and gastric carcinoma. Natural Medicine 3:593.
47. O'Connell MJ, Walworth NC, Carr AM. 2000. The G2-phase DNA-damage checkpoint. Trends in Cell Biology 10:296-303.
48. Omura S, Iwai Y, Hirano A, Nakagawa A, Awaya J, Tsuchya H, Takahashi Y, Masuma R. 1977. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. Journal of Antibiotics (Tokyo) 30:275-282.
49. Orr MS, Reinhold W, Yu L, Schreiber-Agus N, O'Connor PM. 1998. An important role for the retinoblastoma protein in staurosporine-induced G1 arrest in murine embryonic fibroblasts. Journal of Biological Chemistry 273:3803-3807.
50. Pawlik TM, Keyomarsi K. 2004. Role of cell cycle in mediating sensitivity to radiotherapy. International Journal of Radiation, Oncology, Biology and Physics 59:928-942.
51. Philchenkov A, Zavelevich M, Kroczak TJ, Los M. 2004. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Experimental Oncology 26:82-97.
52. Pietenpol JA, Stewart ZA. 2002. Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis. Toxicology 181-182, 475-481.
53. Playle LC, Hicks DJ, Qualtrough D, Paraskeva C. 2002. Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines. British Journal of Cancer 87:352-358.
54. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S. 1995. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Research 55:1643-1648.
55. Rocha S, Soengas MS, Lowe SW, Glanzmann C, Fabbro D, Winterhalter K, Bodis S, Pruschy M. 2000. Protein kinase C inhibitor and irradiation-induced apoptosis: relevance of the cytochrome c-mediated caspase-9 death pathway. Cell Growth & Differentiation 11:491-499.
56. Sato T, Koseki T, Yamato K, Saiki K, Konishi K, Yoshikawa M, Ishikawa I, Nishihara T. 2002. p53-independent expression of p21(CIP1/WAF1) in plasmacytic cells during G(2) cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infection and Immunity 70:528-534.
57. Schnier JB, Nishi K, Goodrich DW, Bradbury EM. 1996. G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637. Proceedings of the National Academy of Sciences of the United States of America 93:5941-5946.
58. Shimizu S, Narita M, Tsujimoto Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487.
59. Shinomiya N, Kuno Y, Yamamoto F, Fukasawa M, Okumura A, Uefuji M, Rokutanda M. 2000. Different mechanisms between premitotic apoptosis and postmitotic apoptosis in X-irradiated U937 cells. International Journal of Radiation, Oncology, Biology and Physics 47:767-777.
60. Teitz T, Lahti JM, Kidd VJ. 2001. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. Journal of Molecular Medicine 79:428-436.
61. Teitz T, Wei T, Liu D, Valentine V, Valentine M, Grenet J, Lahti JM, Kidd VJ. 2002. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Oncogene 21:1848-1858.
62. van Noesel MM, van Bezouw S, Voute PA, Herman JG, Pieters R, Versteeg R. 2003. Clustering of hypermethylated genes in neuroblastoma. Genes, Chromosomes & Cancer 38:226-233.
63. Verheij M, Bartelink H. 2000. Radiation-induced apoptosis. Cell and Tissue Research 301:133-142.
64. Wang Y, Li J, Booher RN, Kraker A, Lawrence T, Leopold WR, Sun Y. 2001. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator. Cancer Research 61:8211-8217.
65. Waskiewicz AJ, Cooper JA. 1995. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Current Opinion in Cell Biology 7:798-805.
66. Watson RE, McKim JM, Cockerell GL, Goodman JI. 2004. The value of DNA methylation analysis in basic, initial toxicity assessments. Toxicological Sciences 79:178-188.
67. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM. 2003. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. Journal of Neurosurgery 98:378-384.
68. Yao SL, Akhtar AJ, McKenna KA, Bedi GC, Sidransky D, Mabry M, Ravi R, Collector MI, Jones RJ, Sharkis SJ, Fuchs EJ, Bedi A. 1996. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nature Medicine 2:1140-1143.
69. Zaugg K, Rocha S, Resch H, Hegyi I, Oehler C, Glanzmann C, Fabbro D, Bodis S, Pruschy M. 2001. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412. Cancer Resarch 61:732-738.
70. Zhivotovsky B, Orrenius S, Brustugun OT, Doskeland SO. 1998. Injected cytochrome c induces apoptosis. Nature 391:449-450.
71. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE. 1993. bcl-2 inhibits death of central neural cells induced by multiple agents. Proceedings of the National Academy of Sciences of the United States of America 90:4533-4537.